/
/
Ein murines Ommaya Xenograft-Modell zur Untersuchung der direkten zielgerichteten Therapie von Leptomeningealerkrankungen
This content is Free Access.
4,715 Views
•
07:17 min
•
January 29, 2021
DOI:
1Department of Neuro-Oncology,H. Lee Moffitt Cancer Center & Research Institute, 2Department of Tumor Biology,H. Lee Moffitt Cancer Center & Research Institute, 3Department of Comparative Medicine,University of South Florida, 4Department of Breast Oncology,H. Lee Moffitt Cancer Center & Research Institute, 5Department of Cancer Physiology,H. Lee Moffitt Cancer Center & Research Institute, 6Department of Drug Discovery,H. Lee Moffitt Cancer Center & Research Institute, 7Department of Medical Oncology,Roswell Park Comprehensive Cancer Center
Summary
Automatically generated
Hier beschreiben wir ein murines Xenograft-Modell, das funktionell einem Ommaya-Reservoir bei Patienten ähnelt. Wir haben die Murine Ommaya entwickelt, um neuartige Therapeutika für die universell tödliche Leptomeningealerkrankung zu untersuchen.
Read Article
Cite this Article
Law, V., Baldwin, M., Ramamoorthi, G., Kodumudi, K., Tran, N., Smalley, I., Duckett, D., Kalinski, P., Czerniecki, B., Smalley, K. S. M., Forsyth, P. A. A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease. J. Vis. Exp. (167), e62033, doi:10.3791/62033 (2021).
Copy